Trial Profile
A Pilot Study of Oral Calcitriol in Patients at High Risk for Lung Cancer.
Status:
Completed
Phase of Trial:
Phase I
Latest Information Update: 09 Nov 2021
Price :
$35
*
At a glance
- Drugs Calcitriol (Primary)
- Indications Lung cancer
- Focus Adverse reactions
- 01 May 2018 Status changed from active, no longer recruiting to completed.
- 01 May 2018 Status changed from active, no longer recruiting to completed.
- 06 Apr 2017 Planned End Date changed from 1 Dec 2017 to 7 Mar 2018.